AQR CAPITAL MANAGEMENT LLC

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$756,322

+$357,967 QoQ

Shares Held

37,572

+52.3% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 182 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. KALV ranks #143 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$756,322	37,572	+52.3%	Shares	Defined	2026-05-15
2025-12-31	$398,355	24,666	-44.7%	Shares	Defined	2026-02-17
2025-09-30	$543,300	44,606	-5.9%	Shares	Other	2025-11-14
2025-06-30	$536,002	47,413	-15.3%	Shares	Other	2025-08-14
2025-03-31	$645,949	55,975	+353.1%	Shares	Other	2025-05-15
2024-09-30	$143,059	12,354	+17.2%	Shares	Defined	2024-11-14
2024-03-31	$124,980	10,538	-51.8%	Shares	Defined	2024-05-15
2023-03-31	$171,725	21,848	-76.8%	Shares	Defined	2023-05-15
2022-12-31	$637,359	94,284	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.